期刊文献+

连锁分析血管紧张素转换酶基因插入/缺失多态性和血管紧张素原M235T基因多态性与肥厚型心肌病的关系 被引量:2

Linkage analysis of the association of genetic polymorphisms of angiotensin converting enzyme and angiotensinogen M235T with hypertrophic cardiomyopathy
原文传递
导出
摘要 目的 连锁分析中国人群血管紧张素转换酶 (ACE)基因插入 /缺失多态性及血管紧张素原 (AGT)M2 3 5T基因多态性与肥厚型心肌病 (HCM)发病的关系。方法 对 63例HCM患者分别用PCR法检测ACE基因插入 /缺失和AGTM2 3 5T基因多态性。结果 HCM患者中ACEDD +AGTTT基因型的比数比高于单基因型 ,其心脏事件发生率高于其他基因型组合者和AGTTT型。结论 同时具有ACEDD +AGTTT基因型者 ,较单基因型发生HCM的风险率显著增高 ;同时具有ACEDD +AGTTT基因型的HCM患者发生心脏事件的危险更大。 Objective To evaluate the association of the genetic polymorphism of angiotensinogen (AGT) and angiotensin converting enzyme (ACE) with the risk of hypertrophic cardiomyopathy (HCM) in Chinese people. Methods Polymerase chain reaction (PCR) was carried out to detect the polymorphisms of ACE and AGT genes in 63 HCM patients. Results In HCM patients, the odds ratio (OR) estimated by linkage analysis of ACE-DD and AGT-TT genotypes was markedly higher when compared with that estimated separately from the ACE-DD or AGT-TT genotype. The risk of cardiac events was higher in HCM patients with both ACE-DD and AGT-TT genotypes than that in those with other combination of ACE and AGT genotypes and also higher than that in those with AGT-TT genotype only. Conclusions Combination of ACE-DD and AGT-TT genotypes may have synergistic effect on the risk of HCM in Chinese people. The risk of cardiac events was much higher in HCM patients with both ACE-DD and AGT-TT genotypes.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2001年第4期231-234,共4页 Chinese Journal of Cardiology
关键词 肥厚型心肌病 血管紧张素原 连锁分析 基因多态性 Cardiomyopathy, hypertrophic Genes Angiotensinogen Peptidyl-Dipeptidase A
  • 相关文献

参考文献7

  • 1杨荣,张馥敏,马文珠,谢勇,贾永平.肥厚型心肌病患者血管紧张素转换酶基因缺失多态性研究[J].南京医科大学学报(自然科学版),2000,20(4):272-274. 被引量:3
  • 2杨荣,南京医科大学学报,2000年,20卷,272页
  • 3Lopez Haldon J,Med Clin Barc,1999年,113卷,161页
  • 4Lechin M,Circulation,1995年,92卷,1808页
  • 5Katsuya T,Lancet,1995年,345卷,1600页
  • 6Marian A J,Lancet,1993年,342卷,1085页
  • 7Rust S,Nucl Acids Res,1993年,21卷,3623页

二级参考文献10

  • 1刘志红,陈朝红,关天俊,张京红,黎磊石.南方汉族人群中血管紧张素转换酶基因多态性的分布特点[J].中华医学杂志,1996,76(10):778-779. 被引量:35
  • 22,Villard E, Tiret L, Visvikis S, et al. Identification of new polymorphism ofangiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACElevels by two-QTL segregation-linkage analysis. Am J Hum Genet, 1996,58:9386
  • 33,Cambien F, Poirier O, Locerf L, et al. Deletion polymorphism in the gene forangiotensin I-converting enzyme is a potent risk factor for myocardial infarction. Nature,1992,359:641
  • 44,Marian AJ, Yu QT, Workman R, et al. Angiotensin convreting enzyme polymorphism inhypertrophic cardiomyopathy and sudden cardiac death. Lancet, 1993,342:1085
  • 55,Lechin M, Quinones MA, Omran A, et al. Angiotensin-I converting enzyme genotypes andleft ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation,1995,92:1808
  • 66,Yoneya K, Okamoto H, Machida M, et al. Angiotensin-coverting enzyme gene polymorphismin Japanese patients with hypertrophic cardiomyopathy. Am Heart J, 1995,130:1089
  • 77,Pfeufer A, Osterziel KJ, Urata H, et al. Angiotensin-converting enzyme and heartchymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol, 1996,78:362
  • 88,Tesson F, Dufour C, Moolman JC, et al. The influence of the angiotensin I convertingenzyme genotype in familial hypertrophic cardiomyopathy varies with the disease genemutation. J Mol Cell Cardiol, 1997,29:831
  • 99,Marian J, Roberts R. Recent advances in the molecular genetics of hypertrophiccardiomyopathy. Circulation, 1995,92:1336
  • 101,Rigat B, Hubert C, Alhenc GF, et al. An insertion/deletionpolymorphism of angiotensin I-converting enzyme gene accounting for half the variance ofserum enzyme levels. J Clin Invest, 1990,86:1343

共引文献2

同被引文献32

  • 1蔡思宇,施育平,俞锋,徐耕.血管紧张素原基因M235T多态性与肥厚型心肌病的关系[J].中华医学遗传学杂志,2004,21(3):280-282. 被引量:6
  • 2罗裕,胡铂,王娟,张代富.家族性肥厚型心肌病分子遗传学研究进展[J].心血管病学进展,2005,26(6):663-667. 被引量:3
  • 3况少青,于金德,陆林,何汝敏,龚兰生,陈赛娟,陈竺.肥厚性心肌病患者心脏β-肌凝蛋白重链基因点突变的研究[J].中华心血管病杂志,1996,24(2):111-114. 被引量:10
  • 4[1]Jarcho J A,Mckenna W,Pater P J,et al.Mapping of a gene for familial hyper-trophic cardiomyopathy to chromo-some 14q1[J].New Eng1 J Medicine,1989,321:1372-1378.
  • 5[2]Jens Mogensen,Ib C.Klausen,AndersK,et al.α-cardiac actin is a novel disease gene in familial hypertrophic cardiomypa-thy[J].J ClinInvest,1999,103:R39-R43.
  • 6[3]Manatsu S,Megumi T,Tsuguya S,et al.Structural analysis of the titin gene in hy-pertrophic cardiomyopathy:identification of a novel disease gene[J].Biochemical and Biophsical Research Communication,1999,262:411.
  • 7[4]Bowles N E,Bowles K R,Towbin J A,et al.The"Final Common Pathway"hy-pothesis and inherited cardiovascular dis-ease.the role of cytoskeletal proteins in dilated cardiomyopathy[J].Herz,2000,25:168.
  • 8[5]Seidman J G,Seidman C.The genetic basis for cardiomyopathy:from mutation idetifica-tion to mechanistic paradigms[J].Cell,2001,104:557-567.
  • 9[6]Sweeney H L,Feng H S,Yang Z,et al.Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy:insights into disease pathogenesis and troponin function[J].J Lipid Res,1999,40:178-182.
  • 10[7]Cuda G,Fananapazir L,Epstein N D,et al.The in vitro motility activity of beta-cardiacmyosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomycpathy[J].J Muscle Res Cell Motil,1997,18:275-283.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部